Chronic News and Research

RSS

Studies examine risk factors for hospital readmission

In two studies published today in the Journal of Hospital Medicine, the risk factors for readmission to the hospital are examined based upon general medicine inpatients and those with at least two admissions in a six-month period. Alongside clinical factors such as having cancer, chronic diseases such as heart failure or lung disease, or being on high-risk medications, the studies identified other factors which increase the likelihood of a patient being readmitted which could help hospitalists focus in on these groups.

13 Oct 2010

The Partnership at Drugfree.org issues statement on FDA approval of VIVITROL for opioid dependence

The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and all those who are struggling to overcome opioid addiction. Addiction, a disease of the human brain, is a chronic illness while opioid dependence is frequently characterized by relapse.

13 Oct 2010

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.

From Baxter International Inc. 13 Oct 2010

New evidence supports possible link between XMRV and prostate cancer

Xenotropic murine leukemia virus-related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection.

13 Oct 2010

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

ERYtech Pharma is pleased to announce it has signed a collaborative research agreement with Genzyme Corporation to explore the feasibility of developing a novel therapeutic enzyme formulation using ERYtech's proprietary technology.

13 Oct 2010

Alkermes' VIVITROL medication for treatment of opioid dependence

Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL(naltrexone for extended-release injectable suspension) for the prevention of relapse to opioid dependence, following opioid detoxification.

13 Oct 2010

New 2010 clinical practice guidelines for diagnosis and management of osteoporosis in Canada released

Today, Osteoporosis Canada released its 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada, published in the Canadian Medical Association Journal. The new guidelines represent a paradigm shift in the prevention and treatment of osteoporotic fractures, moving the focus from treating low bone mineral density (BMD) to better identifying fractures caused by weakened bones (fragility fractures).

12 Oct 2010

VNSNY adopts advanced information technology to improve patient care

Unlike most home healthcare agencies, which have restricted the use of computer programs to such non-patient-care items as billing, the Visiting Nurse Service of New York has adopted advanced information technology in order to improve patient care. One of the results, documented in a new publication, is a significant 10% reduction in patient episodes ending in hospitalization, from 37% to 27% over the years 2001-2009.

12 Oct 2010

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Adeona Pharmaceuticals, Inc., announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline.

12 Oct 2010

Minnesota Foundation announces collaborative effort to improve health of underserved populations

In a report released this week, the Blue Cross and Blue Shield of Minnesota Foundation highlights the accomplishments of a collaborative effort to improve the health of underserved populations through the training and use of community health workers, titled Community health workers in Minnesota: Bridging barriers, expanding access, improving health.

12 Oct 2010

Integrated Research Network to analyze payor health policy for chronic pain medications

HealthCore's Integrated Research Network is enrolling family physicians, general practitioners, internists, neurologists, rheumatologists, endocrinologists, and pain management specialists in a first-of-its-kind study to analyze payor health policy for chronic pain medications.

12 Oct 2010

$Photographic exhibition reveals devastating impact of spinal osteoporotic fractures$

Photographic exhibition reveals devastating impact of spinal osteoporotic fractures

At a press conference held in Brussels today, the International Osteoporosis Foundation (IOF), the Belgian Bone Club and the European Parliament Osteoporosis Interest Group called on health care professionals and health policy officials in Europe to take action to prevent spinal fractures. The call to action was made at the launch of a unique photographic essay, 'snap! the breaking spine', leading up to World Osteoporosis Day on October 20, 2010.

12 Oct 2010

Behavioral management and preventive medication can combat migraine: Research

The combination of preventive medication and behavioral changes offered significant relief for 77 percent of the individuals enrolled in a study aimed at combating frequent, disabling migraine headaches, according to new Ohio University research published this week in the British Medical Journal.

12 Oct 2010

Albireo reports positive results from A3309 Phase IIb study in chronic idiopathic constipation

Albireo today announced positive top-line results from a Phase IIb study in chronic idiopathic constipation (CIC) assessing efficacy and safety of three different dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight week trial. Analyses of the data show clinically meaningful and statistically significant improvement for patients treated with A3309 compared to placebo-treated patients.

12 Oct 2010

Physical and psychological factors contribute to somatic symptoms: Report

Patients with cancer who experience pain or depression also have a high rate of physical symptoms, such as fatigue, dry mouth and nausea, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

12 Oct 2010

$Osteoporosis Canada issues new guidelines to prevent fragility fractures$

Osteoporosis Canada issues new guidelines to prevent fragility fractures

Comprehensive new guidelines from the Osteoporosis Canada aimed at preventing fragility fractures in women and men over the age of 50 are published in CMAJ.

12 Oct 2010

Loyola continues mandatory employee flu-vaccination policy for second straight year

The best way to prevent the spread of the flu to patients in a medical setting would be to require all health-care workers to get an annual flu shot, says the American Academy of Pediatrics.

12 Oct 2010

Physician shortage expected to balloon to 91,500 in 2020

News outlets report on workforce issues, including the doctor shortage, Medicaid pay cuts and the effects of long work hours on medical residents.

12 Oct 2010

New, multidisciplinary Senior Adult Oncology Center established at Kimmel Cancer Center

The odds of developing some type of cancer increase with age; sixty percent of cancer in the United States occurs in persons aged 65 and older. At the same time, senior patients may have acute or chronic diseases that make treating their cancer challenging. That's why the Kimmel Cancer Center at Jefferson has established a new, multidisciplinary Senior Adult Oncology Center to provide a comprehensive consultation for senior patients in order to meet those special challenges.

12 Oct 2010

Researchers investigate mechanism of immune system to decipher gut-dwelling worms

A billion people living in underdeveloped areas around the world are infected with parasitic helminthes, worms that survive by residing in and feeding on their hosts. These infestations can cause chronic intestinal (and occasionally systemic) illnesses leading to long-term disability. Irah King and Markus Mohrs, biomedical researchers at the Trudeau Institute, are investigating illnesses caused by these gut-dwelling worms in an effort to decipher how immune cells send and receive signals that determine the specific immune response to mount.

12 Oct 2010

Chronic News and Research

Studies examine risk factors for hospital readmission

The Partnership at Drugfree.org issues statement on FDA approval of VIVITROL for opioid dependence

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

New evidence supports possible link between XMRV and prostate cancer

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

Alkermes' VIVITROL medication for treatment of opioid dependence

New 2010 clinical practice guidelines for diagnosis and management of osteoporosis in Canada released

VNSNY adopts advanced information technology to improve patient care

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Minnesota Foundation announces collaborative effort to improve health of underserved populations

Integrated Research Network to analyze payor health policy for chronic pain medications

Photographic exhibition reveals devastating impact of spinal osteoporotic fractures

Behavioral management and preventive medication can combat migraine: Research

Albireo reports positive results from A3309 Phase IIb study in chronic idiopathic constipation

Physical and psychological factors contribute to somatic symptoms: Report

Osteoporosis Canada issues new guidelines to prevent fragility fractures

Loyola continues mandatory employee flu-vaccination policy for second straight year

Physician shortage expected to balloon to 91,500 in 2020

New, multidisciplinary Senior Adult Oncology Center established at Kimmel Cancer Center

Researchers investigate mechanism of immune system to decipher gut-dwelling worms

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News